# Dentis receives China NMPA approval for SQ Implant, plans direct sales

Dentis has received NMPA approval for its premium implant product 'SQ Implant' in China, enabling direct sales. The company plans to ship an initial volume worth $2 million starting July 2023 and aims to expand sales to over $8 million within the year.

- Type: Product launch
- Announced: 2023-07-10
- Where: China, China
- Value: $2.00M
- Status: announced
- Products: SQ Implant
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Dentis](https://endata.com/companies/69414.md)

## Sources

- [asiae.co.kr](https://www.asiae.co.kr/en/article/2023071010432916368), 2023-07-10: "We plan to ship an initial volume worth 2 million USD starting this month."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.